Document is current

Any future updates will be listed below

A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer

Crossref DOI link: https://doi.org/10.1038/s41392-024-02115-5

Published Online: 2025-01-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark